Agenus Inc. (AGEN) — Analysis Summary
Agenus Inc. (AGEN) has a market cap of $145.75M with year-over-year revenue growth of +10.4%. Net margin stands at -2.7%. The stock trades at a P/E ratio of 2.3.
Key Takeaways
- Revenue changed +10.4% year-over-year
- Net margin of -2.7%
- P/E ratio of 2.3
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, AGEN posted revenue growth of +10.4% and trades at a P/E of 2.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.